SUPRIYA LIFESCIENCE
Back to Balance Sheet
|
SUPRIYA LIFESCIENCE Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹38 Cr | ₹33 Cr | ₹29 Cr | ₹25 Cr | ₹19 Cr |
What is the latest Total Non-Current Liabilities ratio of SUPRIYA LIFESCIENCE ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹38 Cr |
| Mar2025 | ₹33 Cr |
| Mar2024 | ₹29 Cr |
| Mar2023 | ₹25 Cr |
| Mar2022 | ₹19 Cr |
How is Total Non-Current Liabilities of SUPRIYA LIFESCIENCE Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹38 Cr | 14.78 | |
| Mar2025 | ₹33 Cr | 15.24 | |
| Mar2024 | ₹29 Cr | 15.72 | |
| Mar2023 | ₹25 Cr | 29.23 | |
| Mar2022 | ₹19 Cr | - | |
Compare Total Non-Current Liabilities of peers of SUPRIYA LIFESCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUPRIYA LIFESCIENCE | ₹6,990.6 Cr | 2.9% | -12.5% | 12.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,991.0 Cr | 0.2% | -5.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹256,310.0 Cr | 4.9% | -0.5% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,604.0 Cr | -1.1% | -8.5% | 28.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,722.0 Cr | 7.8% | 11% | 1.2% | Stock Analytics | |
| CIPLA | ₹109,628.0 Cr | 2.3% | -2.7% | -18.9% | Stock Analytics | |
SUPRIYA LIFESCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUPRIYA LIFESCIENCE | 2.9% |
-12.5% |
12.7% |
| SENSEX | 1.2% |
0.4% |
-12.2% |
You may also like the below Video Courses